Literature DB >> 16886634

An in vivo analysis of the herbal compound essiac.

Blair J N Leonard1, Deborah A Kennedy, Fong-Chi Cheng, Keng-Kuang Chang, Dugald Seely, Edward Mills.   

Abstract

BACKGROUND: Essiac is a herbal compound that has been in common use with cancer patients in North America for over 80 years. Despite its relatively widespread use, there are no peer-reviewed published reports of in vivo studies regarding the use of this compound.
MATERIALS AND METHODS: Essiac was administered orally to test animals prior to all experiments. Standard assays to test protection from ethanol-induced gastric ulceration and carbon tetrachloride-induced hepatic injury were performed on Wistar rats. Assays of postglucose-load serum glucose and cellular and humoral immune modulation were conducted on ICR and BALB/C mice, respectively.
RESULTS: Essiac demonstrated a modest gastric protective effect via reduction of ethanol-induced gastric ulceration. However, Essiac did not demonstrate significant hepatoprotective, hypoglycemic or immunomodulatory properties.
CONCLUSION: Essiac, administered in established in vivo experimental models, did not significantly demonstrate its purported physiological modifying effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16886634

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Unreported use of an herbal supplement resulting in decreased clearance of intravenous busulfan in a patient undergoing auto-SCT.

Authors:  J Carter; R F Yeh; I Braunschweig; S K Barta
Journal:  Bone Marrow Transplant       Date:  2013-11-04       Impact factor: 5.483

2.  A Comparison between Water and Ethanol Extracts of Rumex acetosa for Protective Effects on Gastric Ulcers in Mice.

Authors:  Ji-Yeong Bae; Yoon Seok Lee; Sun Young Han; Eun Ju Jeong; Mi Kyeong Lee; Jae Yang Kong; Dong Hoon Lee; Kyeong Jae Cho; Haeng-Soon Lee; Mi-Jeong Ahn
Journal:  Biomol Ther (Seoul)       Date:  2012-07       Impact factor: 4.634

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.